Treatment of choice in basal cell carcinoma at inner canthus of eye is
The treatment options for BCC vary depending on the location, size, and subtype. Common treatments include surgical excision, Mohs surgery, cryotherapy, radiation, and topical treatments. However, the inner canthus is a delicate area with critical structures like the lacrimal duct and eyelid margins. So, the treatment must be precise to avoid damage to these structures while ensuring complete removal of the cancer.
Mohs surgery is often the preferred method for BCC in cosmetically sensitive areas because it allows for maximum tissue preservation while achieving clear margins. This technique involves removing the tumor layer by layer and examining each layer under a microscope immediately, which helps in preserving healthy tissue. Since the inner canthus is a high-risk area for recurrence and requires meticulous excision, Mohs would be ideal here.
Now, looking at the options, the correct answer is likely Mohs surgery. The other options might include alternatives like simple excision, which might not be as precise, or radiation therapy, which could be used but might not be first-line. I need to make sure that the reasoning is solid. The key points here are the need for precision and margin control in a sensitive area, which Mohs provides. The explanation should highlight why Mohs is better than other options in this specific location.
**Core Concept**
Basal cell carcinoma (BCC) at the inner canthus requires precise margin control to preserve critical anatomical structures like the lacrimal duct and eyelid margins. **Mohs micrographic surgery** is the gold standard for BCC in cosmetically or functionally sensitive areas due to its high cure rate and tissue conservation.
**Why the Correct Answer is Right**
**Mohs surgery** involves layer-by-layer excision with immediate histopathological analysis of 100% of the surgical margins. This ensures complete tumor removal while sparing healthy tissue, critical for the inner canthus where structures like the medial rectus muscle and lacrimal apparatus are at risk. Studies show a 5-year cure rate >95% for BCC in this location, outperforming standard excision or radiation.
**Why Each Wrong Option is Incorrect**
**Option A:** *Cryotherapy* is ineffective for BCC due to its inability to confirm margin clearance, leading to high recurrence rates.
**Option B:** *Standard excision* without margin analysis risks incomplete removal in high-risk areas, increasing recurrence.
**Option C:** *Radiation therapy* is reserved for inoperable cases but has lower local control rates (70–80%) compared to Mohs.
**Clinical Pearl**
Never use cryotherapy or radiation as first-line for BCC in the inner canthus. Mohs is non-negotiable for this location—its precision prevents complications like lacrimal duct injury or eyelid malposition.
**Correct Answer: C. Mohs micrographic surgery**